Otonomy
is a California-based biopharmaceutical company that researches and develops novel therapeutics for patients with hearing disorders... Read moreOtonomy
is a California-based biopharmaceutical company that researches and develops novel therapeutics for patients with hearing disorders... Read more
News
Oct 17, 2024
Openpr
Otonomy: Cholesteatoma Treatment Market Share, Trends, Top Players, Segments and Forecasts Research | WraSer LLC, Novartis AG, Otonomy Inc.
May 11, 2023
Usalifesciences
Otonomy: Otonomy to Report First Quarter 2022 Financial Results and Provide Corporate Update
May 11, 2023
Usalifesciences
Otonomy: Otonomy to Host Virtual Investor R&D Event on March 22, 2022
May 11, 2023
Usalifesciences
Otonomy: Otonomy Completes Enrollment in Phase 2 Clinical Trial of OTO-313 in Tinnitus
Mar 30, 2023
Endpoints News
Otonomy: Hearing-focused biotech grabs trio of programs from Otonomy's fire sale
Mar 29, 2023
BioSpace
Otonomy: Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Dec 29, 2022
Nasdaq
Otonomy: Elk Capital Makes Investment in Otonomy
Dec 28, 2022
Newschannelnebraska
Otonomy: Delisting of Securities of Tuscan Holdings Corp. II; Clovis Oncology, Inc.; ZyVersa Therapeutics, Inc.; Otonomy, Inc., and Forward Pharma A/S from The Nasdaq Stock Market
Dec 22, 2022
Usalifesciences
Otonomy: Otonomy Announces Change in Stock Exchange Listing
Dec 21, 2022
The San Diego Union Tribune
Otonomy: San Diego biotech that studied tinnitus, ear diseases is closing after failing to find a buyer
Otonomy Competitors
1
2
3
4
5
6
7
8
9
10